PPD, Inc. (Nasdaq: PPD) has been recognized with two global excellence awards for its effective learning programs, honoring the company’s high-performing employee development initiatives supporting delivery of global operational excellence and innovative solutions to customers.
PPD, Inc. (Nasdaq: PPD) has been recognized as one of the best in the world for its successful employee learning and development programs by the Association for Talent Development (ATD), a global organization that empowers and supports professionals to develop talent in the workplace.
PPD, Inc. (Nasdaq: PPD), a leading global contract research organization, will host a conference call on Thursday, July 29, 2021, at 7 a.m. (U.S. Eastern Time) to discuss its second quarter 2021 financial results.
PPD, Inc. (Nasdaq: PPD) has been named “Most Innovative CRO” by North Carolina’s Triangle Business Journal, recognizing the global contract research organization’s strong performance in a year shaped by the COVID-19 pandemic.
PPD, Inc. (Nasdaq: PPD), a leading global contract research organization, held a grand opening ceremony for its new multipurpose laboratory in Suzhou, China, to support Western and China -based pharmaceutical and biotech companies managing China research studies.
PPD, Inc. (Nasdaq: PPD ) has been recognized for excellence in the CRO Leadership Awards for the 10th consecutive year, earning praise for its clinical research capabilities and customer compatibility in a survey of pharmaceutical and biotech professionals conducted for Clinical Leader and Life Science Leader magazines.
PPD, Inc. (Nasdaq: PPD), a leading global contract research organization, is expanding its Athlone, Ireland, GMP (good manufacturing practices) laboratory, significantly increasing the size of its current facility and adding cell and gene therapy testing to the operation’s portfolio of services.